Saturday, September 18, 2021
wellness India Expo
Home Tags COVAXIN

Tag: COVAXIN

COVAXIN demonstrates interim clinical efficacy of 78% in phase 3 trials

The second interim results showed India’s First COVID-19 Vaccine had demonstrated strong primary efficacy against severe COVID-19 disease.......................

Bharat Biotech to ramp up Covaxin production by 700 million doses...

The capacity expansion has been implemented across multiple facilities in Hyderabad and Bangalore, to reach ~ 700 million doses per year, one of the largest production capacities for Inactivated viral vaccines worldwide.................................

Govt targets 6-7 fold increase in COVAXIN production by August, 2021

The current production capacity of indigenously developed Covaxin vaccine is expected to be doubled by May-June 2021 and then increased nearly 6-7 fold by July - August 2021 under Mission COVID Suraksha......................

Govt fast tracks emergency approvals for foreign produced COVID-19 vaccines

A lot many vaccines are expected to be granted Emergency Use Authorization in other countries for expanding the basket of vaccines for domestic use and hasten the pace and coverage of vaccination....................

COVID-19 vaccine: Keeping the options open!

Conversation on what happens once you get the vaccine by Dr Gajendra Singh, Public Health Expert.................

Bharat Biotech’s COVAXIN Phase 3 results show interim clinical efficacy of...

Data from 25,800 participants that received the COVAXIN vaccine or placebo in a 1:1 ratio showed that the vaccine candidate was well-tolerated. It demonstrated 81% interim efficacy in preventing COVID-19 after the second dose....................

Bharat Biotech confirms deal with Brazil to supply 20 million doses...

It has signed an agreement for the delivery of COVAXIN during the second and third quarter of the year 2021.....................

Ukraine Health Minister visits Bharat Biotech vaccine plant at Hyderabad

The representatives from the Central Asian nation of 41 million people took a tour of the world-class Bio-Safety Level 3 manufacturing facility....................

BioAsia 2021 to honor Bharat Biotech with Genome Valley Excellence Award

Dr Krishna M. Ella, Mrs.Suchitra Ella and Dr Balram Bhargav are being honored in BioAsia 2021...............

Approval in India paves way for Bharat Biotech to take Covaxin...

Recently, Bharat Biotech has applied for regulatory approval to conduct clinical trials in Bangladesh and has applied for EUA in the Philippines.....................